全文获取类型
收费全文 | 184631篇 |
免费 | 1485篇 |
国内免费 | 104篇 |
专业分类
耳鼻咽喉 | 1197篇 |
儿科学 | 6844篇 |
妇产科学 | 3315篇 |
基础医学 | 17471篇 |
口腔科学 | 1742篇 |
临床医学 | 13149篇 |
内科学 | 33375篇 |
皮肤病学 | 751篇 |
神经病学 | 17437篇 |
特种医学 | 9321篇 |
外科学 | 30010篇 |
综合类 | 2330篇 |
一般理论 | 3篇 |
预防医学 | 18464篇 |
眼科学 | 2848篇 |
药学 | 10124篇 |
中国医学 | 645篇 |
肿瘤学 | 17194篇 |
出版年
2023年 | 56篇 |
2022年 | 188篇 |
2021年 | 342篇 |
2020年 | 177篇 |
2019年 | 304篇 |
2018年 | 22195篇 |
2017年 | 17560篇 |
2016年 | 19741篇 |
2015年 | 1220篇 |
2014年 | 1213篇 |
2013年 | 1249篇 |
2012年 | 7725篇 |
2011年 | 21712篇 |
2010年 | 19170篇 |
2009年 | 11906篇 |
2008年 | 20034篇 |
2007年 | 22221篇 |
2006年 | 1091篇 |
2005年 | 2727篇 |
2004年 | 3892篇 |
2003年 | 4828篇 |
2002年 | 2923篇 |
2001年 | 352篇 |
2000年 | 478篇 |
1999年 | 259篇 |
1998年 | 288篇 |
1997年 | 289篇 |
1996年 | 161篇 |
1995年 | 164篇 |
1994年 | 151篇 |
1993年 | 95篇 |
1992年 | 92篇 |
1991年 | 123篇 |
1990年 | 162篇 |
1989年 | 96篇 |
1988年 | 90篇 |
1987年 | 67篇 |
1986年 | 56篇 |
1985年 | 64篇 |
1984年 | 45篇 |
1983年 | 47篇 |
1982年 | 51篇 |
1980年 | 57篇 |
1974年 | 27篇 |
1968年 | 24篇 |
1938年 | 60篇 |
1937年 | 25篇 |
1934年 | 31篇 |
1932年 | 56篇 |
1930年 | 46篇 |
排序方式: 共有10000条查询结果,搜索用时 109 毫秒
941.
942.
943.
944.
945.
946.
947.
Marco Cascella Sabrina Bimonte Francesco Saettini Maria Rosaria Muzio 《Journal of paediatrics and child health》2019,55(2):129-135
Children with cognitive disabilities are at greater risk of experiencing pain. It has been shown that this paediatric population often receive inadequate pain management. Pain may be very difficult to assess, especially in a defined subgroup with non‐communicating intellectual disability or severe cognitive disability. Accordingly, several observational pain assessment tools have been proposed to overcome this issue. Due to the absence of an ideal measurement tool, accurate pain assessment requires, after a case‐by‐case analysis, selecting the more appropriate tool or a variety of combined instruments. The aim of this work is to provide a comprehensive review of the pain assessment tools commonly used in cognitively impaired children. Critical discussion on features and clinical applicability may suggest how to overcome this difficult challenge. Furthermore, this review will help further research aiming to design new instruments and to improve already‐in‐use tools. 相似文献
948.
Metabolomics is one of the newer omics fields, and has enabled researchers to complement genomic and protein level analysis of disease with both semi-quantitative and quantitative metabolite levels, which are the chemical mediators that constitute a given phenotype. Over more than a decade, methodologies have advanced for both targeted (quantification of specific analytes) as well as untargeted metabolomics (biomarker discovery and global metabolite profiling). Untargeted metabolomics is especially useful when there is no a priori metabolic hypothesis. Liquid chromatography coupled to mass spectrometry (LC-MS) has been the preferred choice for untargeted metabolomics, given the versatility in metabolite coverage and sensitivity of these instruments. Resolving and profiling many hundreds to thousands of metabolites with varying chemical properties in a biological sample presents unique challenges, or pitfalls. In this review, we address the various obstacles and corrective measures available in four major aspects associated with an untargeted metabolomics experiment: (1) experimental design, (2) pre-analytical (sample collection and preparation), (3) analytical (chromatography and detection), and (4) post-analytical (data processing). 相似文献
949.
950.
Sheffali Gulati 《Indian journal of pediatrics》2018,85(11):1000-1005
About one-third of childhood epilepsy ultimately becomes drug resistant epilepsy. Only about one-third of drug resistant epilepsy is amenable for epilepsy surgery. Epilepsy surgery and vagal nerve stimulation is still beyond the reach of huge proportion of children with pharmacoresistant epilepsy. Ketogenic diet (KD) has been in use for almost a century now all over the world for drug resistant epilepsy, although in between there was a decline in its popularity with advent of newer antiepileptic drugs like valproate, phenytoin and carbamazepine. Again from 1990s there was resurgence of interest in KD for pharmacoresistant epilepsy and in the last two decades several randomized controlled trials and systemic reviews have proved its efficacy beyond any suspicion. Ketogenic diet is a high fat low carbohydrate and low protein diet, which has been found to reduce epileptogenesis in body most probably by production of ketone bodies. Modified Atkin’s Diet (MAD) first introduced in 2003 and Low Glycemic Index Treatment (LGIT) first introduced in 2005 are another two dietary therapies, which are less restrictive, more palatable with fewer adverse effects and comparable efficacy. MAD is also a high fat, low carbohydrate diet, in which high sugar foods are discouraged and protein and fluids are unrestricted. In LGIT, only carbohydrates with Glycemic Index <50 are allowed and carbohydrate intake is restricted to 40–60 g per day. Medium Chain Triglyceride KD (MCT KD) is another alternative, in which there are more food choices as compared to classic KD, with comparable efficacy. 相似文献